SLC5A2 and hydrops fetalis: In this systematic review and meta-analysis of seven randomized controlled trials comprising 11 302 patients, we meta-analyzed the safety and clinical efficacy of SGLT2 inhibitors in reducing mortality and HF in patients with AMI.